A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases
RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. PURPOSE: This phase II trial is studying how well avoiding the hippocampus during whole-brain radiation therapy works in treating patients with brain metastases.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- other : questionnaire administration
- other : laboratory biomarker analysis
- procedure : cognitive assessment
- procedure : quality-of-life assessment
- radiation : whole-brain radiation therapy
- radiation : intensity-modulated radiation therapy
Phase: Phase 2
Ages Eligible For Study: